These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15824107)

  • 1. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
    Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
    Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
    Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
    Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
    Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
    Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.
    Kondraganti S; Gondi CS; McCutcheon I; Dinh DH; Gujrati M; Rao JS; Olivero WC
    Int J Oncol; 2006 Jun; 28(6):1353-60. PubMed ID: 16685436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
    Nalabothula N; Lakka SS; Dinh DH; Gujrati M; Olivero WC; Rao JS
    Int J Oncol; 2007 Mar; 30(3):669-78. PubMed ID: 17273768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
    Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
    BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Lakka SS; Jasti SL; Gondi C; Boyd D; Chandrasekar N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2002 Aug; 21(36):5601-8. PubMed ID: 12165859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
    Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.